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Non-subtype B viruses cause the vast majority of new human immunodeficiency virus type 1 (HIV-1)
infections worldwide and are thus the major focus of international vaccine efforts. Although their geographic
dissemination is carefully monitored, their immunogenic and biological properties remain largely unknown, in
part because well-characterized virological reference reagents are lacking. In particular, full-length clones and
sequences are rare, since subtype classification is frequently based on small PCR-derived viral fragments.
There are only five proviral clones available for viruses other than subtype B, and these represent only 3 of the
10 proposed (group M) sequence subtypes. This lack of reference sequences also confounds the identification
and analysis of mosaic (recombinant) genomes, which appear to be arising with increasing frequency in areas
where multiple sequence subtypes cocirculate. To generate a more representative panel of non-subtype B
reference reagents, we have cloned (by long PCR or lambda phage techniques) and sequenced 10 near-full-
length HIV-1 genomes (lacking less than 80 bp of long terminal repeat sequences) from primary isolates
collected at major epicenters of the global AIDS pandemic. Detailed phylogenetic analyses identified six that
represented nonrecombinant members of HIV-1 subtypes A (92UG037.1), C (92BR025.8), D (84ZR085.1 and
94UG114.1), F (93BR020.1), and H (90CF056.1), the last two comprising the first full-length examples of these
subtypes. Four others were found to be complex mosaics of subtypes A and C (92RW009.6), A and G
(92NG083.2 and 92NG003.1), and B and F (93BR029.4), again emphasizing the impact of intersubtype
recombination on global HIV-1 diversification. Although a number of clones had frameshift mutations or
translational stop codons in major open reading frames, all the genomes contained a complete set of genes and
three had intact genomic organizations without inactivating mutations. Reconstruction of one of these
(94UG114.1) yielded replication-competent virus that grew to high titers in normal donor peripheral blood
mononuclear cell cultures. This panel of non-subtype B reference genomes should prove valuable for structure-
function studies of genetically diverse viral gene products, the generation of subtype-specific immunological
reagents, and the production of DNA- and protein-based subunit vaccines directed against a broader spectrum
of viruses.
One critical question facing current AIDS vaccine develop-
ment efforts is to what extent human immunodeficiency virus
type 1 (HIV-1) genetic variation has to be considered in the
design of candidate vaccines (11, 21, 41, 72). Phylogenetic
analyses of globally circulating viral strains have identified two
distinct groups of HIV-1 (M and O) (33, 45, 61, 62), and 10
sequence subtypes (A to J) have been proposed within the
major group (M) (29, 30, 45, 72). Sequence variation among
viruses belonging to these different lineages is extensive, with
envelope amino acid sequence variation ranging from 24%
between different subtypes to 47% between the two different
groups. Given this extent of diversity, the question has been
raised whether immunogens based on a single virus strain can
be expected to elicit immune responses effective against a
broad spectrum of viruses or whether vaccine preparations
should include mixtures of genetically divergent antigens
and/or be tailored toward locally circulating strains (11, 21, 41,
72). This is of particular concern in developing countries,
where multiple subtypes of HIV-1 are known to cocirculate
and where subtype B viruses (which have been the source of
most current candidate vaccine preparations [10, 21]) are rare
or nonexistent (5, 24, 40, 72).
Although the extent of global HIV-1 variation is well de-
fined, little is known about the biological consequences of this
genetic diversity and its impact on cellular and humoral im-
mune responses in the infected host. In particular, it remains
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unknown whether subtype-specific differences in virus biology
exist that have to be considered for vaccine design. Thus far,
such differences have not been identified. For example, several
studies have shown that there is no correlation between HIV-1
genetic subtypes and neutralization serotypes (38, 42, 46, 68).
Some viruses are readily neutralized, while most are relatively
neutralization resistant (42). Although the reasons for these
different susceptibilities remain unknown, it is clear that neu-
tralization is not a function of the viral genotype (38, 42, 46,
68). Similarly, recent studies have identified vigorous cross-
clade cytotoxic T-lymphocyte (CTL) reactivities in individuals
infected with viruses from several different clades (3, 6), as well
as in recipients of a clade B vaccine (15). These results are very
encouraging, since they suggest that CTL cross-recognition
among HIV-1 clades is much more prevalent than previously
anticipated and that immunogens based on a limited number
of variants may be able to elicit a broad CTL response (6).
Nevertheless, it would be premature to conclude that HIV-1
variation poses no problem for AIDS vaccine design. Only a
comprehensive analysis of genetically defined representatives
of the various groups and subtypes will allow us to judge
whether certain variants differ in fundamental viral properties
and whether such differences will have to be incorporated into
vaccine strategies. Obviously, such studies require well-charac-
terized reference reagents, in particular full-length and repli-
cation-competent molecular clones that can be used for func-
tional and biological studies.
Full-length reference sequences representing the various
subtypes are also urgently needed for phylogenetic compari-
sons. Recent analyses of subgenomic (23, 52, 54, 58) as well as
full-length (7, 18, 53, 60) HIV-1 sequences identified a surpris-
ing number of HIV-1 strains which clustered in different sub-
types in different parts of their genome. All of these originated
from geographic regions where multiple subtypes cocirculated
and are the results of coinfections with highly divergent viruses
(52, 60, 62). Detailed phylogenetic characterization revealed
that most of them have a complex genome structure with
multiple points of crossover (7, 18, 53, 60). Some recombi-
nants, like the “subtype E” viruses, which are in fact A/E
recombinants (7, 18), have a widespread geographic dissemi-
nation and are responsible for much of the Asian HIV-1 epi-
demic (69, 70). In other areas, recombinants appear to be
generated with increasing frequencies since many randomly
chosen isolates exhibit evidence of mosaicism (4, 8, 31, 66, 71).
Since recombination provides the opportunity for evolutionary
leaps with genetic consequences that are far greater than those
of the steady accumulation of individual mutations, the impact
of recombination on viral properties must be monitored. We
therefore need full-length nonrecombinant reference se-
quences for all major HIV-1 groups and subtypes before we
can map and characterize the extent of intersubtype recombi-
nation.
The number of molecular reagents for non-subtype B viruses
is very limited. There are currently only five full-length, non-
recombinant molecular clones available for viruses other than
subtype B (45), and these represent only three of the proposed
(group M) subtypes (A, C, and D). Moreover, only three
clones (all derived from subtype D viruses) are replication
competent and thus useful for studies requiring functional
gene products (45, 48, 65). Given the unknown impact of
genetic variation on correlates of immune protection, subtype-
specific reagents are critically needed for phylogenetic, immu-
nological, and biological studies. In this paper, we report the
cloning (by long PCR and lambda techniques) of 10 near-full-
length HIV-1 genomes from isolates previously classified as
non-subtype B viruses. Detailed phylogenetic analysis showed
that six comprise nonmosaic representatives of five major sub-
types, including two for which full-length representatives have
not been reported. Four others were identified as complex
intersubtype recombinants, again emphasizing the prevalence
of hybrid genomes among globally circulating HIV-1 strains.
We also describe a strategy for the biological evaluation of
long-PCR-derived genomes and report the generation of a
replication-competent provirus by this approach. The effect of
these reagents on vaccine development is discussed.
MATERIALS AND METHODS
Virus isolates. All viruses used in this study were propagated in normal donor
peripheral blood mononuclear cells (PBMCs) and thus represent primary iso-
lates. Their biological phenotype (SI/NSI), year of isolation, relevant epidemio-
logical and clinical information, and appropriate references are summarized in
Table 1. For consistency, isolates are labelled according to World Health Orga-
nization (WHO) nomenclature (28); some isolates have previously been reported
under different names (1, 43), which are listed in parentheses. Preliminary sub-
TABLE 1. Epidemiological and clinical information for study isolates
Isolatea Sexb Age (yr) City Country Riskfactorc
Disease
statusd
Antiviral
therapy
Yr of
isolation Source
e Biological
phenotypef
Preliminary
subtype
assignment
Reference(s)
92UG037 F 31 Entebbe Uganda Het AS No 1992 WHO NSI A 19, 72
92BR025 M 23 Porto Alegre Brazil Hemo AS No 1992 WHO NSI C 19, 72
94UG114 M 31 Butuku Uganda Het AS No 1994 WHO NSI NA
84ZR085 (H85) NAg NA NA Zaire NA AIDS No 1984 TJU NA NA
93BR020 M 52 Rio de Janeiro Brazil Bi AS No 1993 WHO SI F 19, 72
90CF056 (U4056) M NA Bangui CAR Het AS No 1990 PIB NSI U 43
92RW009 F 24 Kigali Rwanda Het AS No 1992 WHO NSI Ah 17, 72
93BR029 M 17 Sao Paulo Brazil NA AS No 1993 WHO NSI Fh 19, 72
92NG083 (JV1083) F 27 Jos Nigeria NA AIDS No 1992 IHV NSI Gh 1
92NG003 (G3) F 24 Jos Nigeria Het AS NA 1992 IHV NSI Gh 1
a Isolates were named according to WHO nomenclature (previous designations are listed in parentheses).
b M, male; F, female.
c Het, heterosexual contact; Bi, bisexual contact; Hemo, hemophiliac patient.
d AS, asymptomatic.
e TJU, Thomas Jefferson University, Philadelphia, Pa.; PIB, Pasteur Institute, Bangui, Central African Republic (CAR); IHV, Institute of Human Virology,
Baltimore, Md.; WHO, World Health Organization, Geneva, Switzerland.
f Determined in MT-2 assay as described previously (72); NSI, non-syncytium inducing; SI, syncytium inducing.
g NA, information not available.
h Isolates identified to be recombinant in the present study.
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type classification was made on the basis of partial env and/or gag gene sequences
(1, 17, 19, 43).
Amplification of near-complete HIV-1 genomes by using long-PCR methods.
Near-full-length HIV-1 genomes were amplified from DNA of short-term-cul-
tured PBMCs essentially as described previously (18, 56) with the GeneAmp XL
kit (Perkin-Elmer Cetus, Foster City, Calif.) and primers spanning the tRNA
primer binding site (upstream primer UP1A: 59-AGTGGCGCCCGAACAGG-
39) and the R/U5 junction in the 39 long terminal repeat (LTR) (downstream
primer Low2: 59-TGAGGCTTAAGCAGTGGGTTTC-39). Some isolates were
amplified with primers containing MluI restriction enzyme sites to facilitate
subsequent subcloning into plasmid vectors (upstream primer UP1AMlu1: 59-T
CTCTacgcgtGGCGCCCGAACAGGGAC-39; downstream primer Low1Mlu1:
59-ACCAGacgcgtACAACAGACGGGCACACACTACTT-39 [lowercase letters
indicate the MluI restriction site]). Whenever possible, PBMC DNAs were di-
luted before PCR analysis to attempt amplification from single proviral tem-
plates. Cycling conditions included a hot start (94°C for 2 min), followed by 20
cycles of denaturation (94°C for 30 s) and extension (68°C for 10 min), followed
by 17 cycles of denaturation (94°C for 30 s) and extension (68°C for 10 min) with
15-s increments per cycle. PCR products were visualized by agarose gel electro-
phoresis and subcloned into pCRII by T/A overhang (92UG037.1, 92BR025.8,
93BR020.1, and 90CF056.1) or following cleavage with MluI into a modified
pTZ18 vector (pTZ18Mlu1) containing a unique MluI site in its polylinker
(94UG114.1, 92RW009.6, 93BR029.4, 92NG083.2, and 92NG003.1). Transfor-
mations were performed in INVaF9 cells (OneShot kit; Invitrogen, San Diego,
Calif.), and colonies were screened by restriction enzyme digestion for full-length
inserts (transformation efficiencies were generally poor, yielding only a few
recombinant colonies; however, once subcloned, full-length genomes were stable
in their respective vectors). One full-length clone per isolate was randomly
chosen for subsequent sequence analysis.
Construction of a full-length and infectious molecular clone of 94UG114.1. A
674-bp fragment spanning most of the viral LTR (lacking positions 1 to 92 of U3
sequences), as well as the untranslated leader sequence preceding gag, was
amplified from 94UG114 PBMC DNA by using primers and conditions de-
scribed previously (18). After sequence confirmation, this LTR fragment was
cloned into the pTZ18Mlu1 vector, which was subsequently cleaved with NarI (in
the primer binding site) and MluI (in the polylinker) to allow the insertion of the
94UG114.1 long-PCR product cleaved with the same restriction enzymes. The
resulting plasmid clone comprised a full-length 94UG114.1 genome with 39 and
59 LTR fragments containing all regulatory elements necessary for viral replica-
tion.
Lambda phage cloning. The 84ZR085.1 genome was cloned by lambda phage
methods as previously described (36). Briefly, high-molecular-weight DNA from
a primary PBMC culture was digested with SacI (an enzyme that cleaves the viral
LTR), fractionated by sucrose gradient centrifugation to enrich for fragments 9
to 15 kb in length, and ligated into purified arms of lgtWes.lB. Ligation products
were packaged in vitro, subjected to titer determination, and plated on LE392
cells. Recombinant phage plaques were screened with a full-length HIV-1 probe
(BH10) (22). One positive phage recombinant was plaque purified, and its
restriction map was determined by multiple enzyme digestions. The viral insert
was released by digestion with SacI and subcloned into pUC19.
Sequence analysis of HIV-1 genomes. 92UG037.1, 92BR025.8, 84ZR085.1,
93BR020.1, 90CF056.1, 92RW009.6, and 93BR029.4 were sequenced by the
shotgun sequencing approach (37). Briefly, viral genomes were released from
their respective plasmid vectors by cleavage with the appropriate restriction
enzymes, purified by gel electrophoresis, and sonicated (model XL2020 sonica-
tor; Heat System Inc., Farmingdale, N.Y.) to generate randomly sheared DNA
fragments of 600 to 1,000 bp. Following purification by gel electrophoresis,
fragments were end repaired with T4 DNA polymerase and Klenow enzyme and
ligated into SmaI-digested and dephosphorylated M13 or pTZ18 vectors. Ap-
proximately 200 shotgun clones were sequenced for each viral genome by using
cycle-sequencing and dye terminator methods on an automated DNA Sequena-
tor (model 377A; Applied Biosystems, Inc.). Sequences were determined for
both strands of DNA. 92UG114.1, 92NG083.2, and 92NG003.1 were sequenced
directly by the primer-walking approach (primers were designed approximately
every 300 bp along the genome for both strands). Proviral contigs were assem-
bled from individual sequences with the Sequencher program (Gene Codes
Corp., Ann Arbor, Mich.). Sequences were analyzed with Eugene (Baylor Col-
lege of Medicine, Houston, Tex.) and MASE (12).
Phylogenetic tree analysis. Phylogenetic relationships of the newly derived
viruses were estimated from sequence comparisons with previously reported
representatives of HIV-1 group M (45). Multiple gag and env sequence align-
ments were obtained from the Los Alamos sequence database (http://hiv-web
.lanl.gov/HTML/alignments.html). Newly derived gag and env sequences were
added to these alignments by using the CLUSTAL W profile alignment option
(67) and adjusted manually with the alignment editor MASE (12). All partial
sequences were removed from these alignments. Sites where there was a gap in
any of the remaining sequences, as well as areas of uncertain alignment, were
excluded from all sequence comparisons. Pairwise evolutionary distances were
estimated by Kimura’s two parameter method to correct for superimposed sub-
stitutions (26). Phylogenetic trees were constructed by the neighbor-joining
method (55), and the reliability of topologies was estimated by performing
bootstrap analysis with 1,000 replicates (13). NJPLOT was used to draw trees for
illustrations (49). Phylogenetic relationships were also determined by using max-
imum-parsimony (with repeated randomized input orders; 10 iterations) and
maximum-likelihood approaches, implemented with the programs DNAPARS
and DNAML from the PHYLIP package (14).
Complete genome alignment. All newly derived HIV-1 genome sequences
were aligned with previously reported (45) full-length representatives of HIV-1
subtype A (U445), B (LAI, RF, OYI, MN, SF2), C (C2220), D (ELI, NDK,
Z2Z6), and “E” (90CF402.1, 93TH253.3, CM240), as well as SIVcpzGAB as an
outgroup, by using the CLUSTAL W (67) profile alignment option (the align-
ment includes the untranslated leader sequence, gag, pol, vif, vpr, tat, rev, vpu, env,
nef, and available 39 LTR sequences). Sequences that had to be excluded from
any particular analysis were removed only after gap tossing was performed on the
complete alignment containing all sequences. This ensured that all positions
were comparable in different runs with different sequences. The complete ge-
nome alignment is available upon request.
Diversity plots. The percent diversity between selected pairs of sequences was
determined by moving a window of 500 bp along the genome alignment in 10-bp
increments. The divergence values for each pairwise comparison were plotted at
the midpoint of the 500-bp segment.
Bootstrap plots. Bootscanning was performed on neighbor-joining trees by
using SEQBOOT, DNADIST (with Kimura’s correction), NEIGHBOR, and
CONSENSUS from the PHYLIP package (14) for a window of 500 bp moving
along the alignment in increments of 10 bp. We evaluated 1,000 replicates for
each phylogeny. The program ANALYZE from the bootscanning package (57)
was used to examine the clustering of the putative hybrid with representatives of
the subtypes presumed to have been involved in the recombination event. The
bootstrap values for these sequences were plotted at the midpoint of each
window.
Exploratory tree analysis. Exploratory tree analysis was performed by the
bootstrap plot approach described above, except in this case an increment of 100
bp was used and each neighbor-joining tree was viewed with DRAWTREE from
the PHYLIP package (14). In addition, all full-length sequences (except known
recombinants) were included in the analysis.
Informative site analysis. To estimate the location and significance of cross-
overs, each putative hybrid sequence was compared with a representative of each
of the two subtypes inferred to have been involved in the recombination event
and an appropriate outgroup. Recombination breakpoints were mapped by ex-
amining the linear distribution of phylogenetically informative sites supporting
the clustering of the hybrid with each of the two “parental” subtypes, essentially
as described previously (52, 53). Potential breakpoints were inserted between
each pair of adjacent informative sites, and the extent of heterogeneity between
the two sides of the breakpoint, with respect to numbers of the two kinds of
informative site, was calculated as a 2 3 2 chi-square value; the likely breakpoint
was identified as that which gave the maximal chi-square value. Since the align-
ments contained more than one putative crossover, this analysis was performed
by looking for one and two breakpoints at a time and repeated on subsections of
the alignment defined by breakpoints that had already been identified. To assess
the probability of obtaining (by chance) chi-square values as high as those
observed, 10,000 random permutations of the informative sites were examined.
DNA transfection and viral infectivity studies. Ten micrograms of the recon-
structed 94UG114.1 plasmid subclone was transfected into 293 T cells by a
calcium phosphate precipitation method (2). Two days after infection, cultured
supernatants were analyzed for reverse transcriptase (RT) activity and used to
infect phytohemagglutinin (PHA)-stimulated normal donor PBMCs (20). Cul-
tures were monitored for virus replication every 3 to 4 days.
Nucleotide sequence accession numbers. The GenBank accession numbers for
the near-full length HIV-1 proviral sequences reported in this study are listed in
Table 2.
RESULTS
Molecular cloning of non-subtype B HIV-1 isolates. The
purpose of this study was to (i) molecularly clone a panel of
near-full-length reference genomes for non-subtype B isolates
of HIV-1, (ii) determine their nucleotide sequence and phylo-
genetic relationships, and (iii) generate proviral constructs for
biological and functional studies. To accomplish this, we se-
lected 10 geographically diverse HIV-1 isolates, 7 of which had
previously been classified as members of (group M) subtypes A
(92UG037 and 92RW009), C (92BR025), F (93BR020 and
93BR029), and G (92NG003 and 92NG083) on the basis of env
(17, 19) and/or gag sequences (1). The remaining three
(84ZR085, 90CF056, and 94UG114) were chosen because they
originated from major epicenters of the African AIDS epi-
demic, including a potential vaccine evaluation site (94UG114).
In addition, 90CF056 was of interest because it did not fall into
any known subtype at the time of its first genetic characteriza-
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tion (43). Table 1 summarizes available demographic and clin-
ical information, as well as biological data concerning the iso-
late phenotype (SI/NSI). Only viruses grown in normal donor
PBMCs were selected for analysis.
Of the 10 viral genomes, 9 were cloned by long-PCR meth-
ods with primers homologous to the tRNA primer binding site
(upstream primer) and the polyadenylation signal in the 39
LTR (downstream primer). This amplification strategy gener-
ated near-full-length genomes containing all coding and regu-
latory regions, except for 70 to 80 bp of 59 unique LTR se-
quences (U5). All isolates, regardless of subtype classification,
yielded long-PCR products with the same set of primer pairs.
In some instances, genomes were amplified with primers con-
taining MluI restriction enzyme sites. This greatly facilitated
subsequent subcloning into a plasmid vector (Table 2). One
provirus (84ZR085.1) was cloned by standard lambda phage
techniques (36) with SacI sites in the viral LTRs as the cloning
enzymes.
Sequence analysis of near-full-length HIV-1 genomes. All 10
HIV-1 genomes were sequenced in their entirety by either
shotgun sequencing or primer-walking approaches. The long-
PCR-derived clones ranged in size from 8,952 to 8,999 bp and
spanned the genome from the primer binding site to the R/U5
junction of the 39 LTR. The lambda phage-derived 84ZR085.1
genome was 8,975 bp in length and ranged from the 59 TAR
domain to the 39 U3 region (unlike most other HIV-1 strains,
84ZR085.1 contains two SacI sites in the LTR). Inspection of
potential coding regions revealed that all clones contained the
expected reading frames for gag, pol, vif, vpr, tat, rev, vpu, env,
and nef. In addition, all major regulatory sequences, including
promoter and enhancer elements in the LTR, the packaging
signal, and splice sites, appeared to be intact. None of the
genomes had major deletions or rearrangements, although in-
spection of the deduced protein sequences identified inactivat-
ing mutations in 7 of the 10 clones (Table 2). However, most of
these were limited to point mutations in single genes and were
thus amenable to repair. Only two genomes (92NG003.1 and
92NG083.2) contained stop codons, small deletions, and
frameshift mutations in several genes, rendering them multiply
defective. Importantly, no inactivating mutations were identi-
fied in 94UG114.1, 93BR020.1, and 90CF056.1, suggesting that
these clones encoded biologically active genomes (Table 2).
Phylogenetic analyses in gag and env regions. To determine
the phylogenetic relationships of the newly characterized vi-
ruses, we first constructed evolutionary trees from full-length
gag and env sequences. This was done to confirm the authen-
ticity of previously characterized strains, classify the new vi-
ruses, and compare viral branching orders in trees from two
genomic regions. The results confirmed a broad subtype rep-
resentation among the selected viruses (Fig. 1). Strains fell into
six of the seven major (non-B) clades, including three for which
full-length sequences are not available (i.e., F, G, and H).
However, comparison of the gag and env topologies also iden-
tified two strains with discordant branching orders. 92RW009.6
grouped with subtype C viruses in gag but with subtype A
viruses in env. Similarly, 93BR029.4 clustered with subtype B
viruses in gag but with subtype F viruses in env. These different
phylogenetic positions were supported by high bootstrap val-
ues and thus indicated that these two strains were intersubtype
recombinants.
Diversity plots. To characterize the two putative recombi-
nants as well as the other eight strains in regions outside gag
and env, we performed pairwise sequence comparisons with
available full-length sequences from the database. A multiple
genome alignment was generated which included the new se-
quences as well as U455 (subtype A); LAI, RF, OYI, MN, and
SF2 (subtype B); C2220 (subtype C); ELI, NDK, and Z2Z6
(subtype D); and 90CF402.1, 93TH253.3, and CM240 (“sub-
type E”). The percent nucleotide sequence diversity between
sequence pairs was then calculated for a window of 500 bp
moved in steps of 10 bp along the alignment. Importantly,
distance values were calculated only after all sites with a gap in
any of the sequences were removed from the alignment. This
ensured that all comparisons were made across the same sites.
Figure 2 depicts selected distance plots for the newly char-
acterized viruses. For example, in panel 1, 93BR020.1 (putative
subtype F) is compared to U455 (subtype A), NDK (subtype
D), C2220 (subtype C), and 90CF056.1 (putative subtype H).
The resulting plots all exhibit very similar diversity profiles
characterized by alternating regions of sequence variability and
conservation (values range from 7% divergence near the 59 and
39 ends of pol to 30% in the segment of env encoding the V3
region). Moreover, the four plots are virtually superimposable,
indicating that 93BR020.1 is roughly equidistant from U455,
NDK, C2220, and 90CF056.1 over the entire length of its
genome. A very similar set of distance curves was also obtained
from comparisons of 90CF056.1 with 93BR020.1, U455, NDK,
and C2220 (panel 2) and from comparisons of both 93BR020.1
and 90CF056.1 with representatives of subtype B and “E”
(data not shown). These results indicating that 93BR020.1 and
90CF056.1 are equidistant from each other as well as from
members of subtypes A, B, C, D, and “E,” together with the
TABLE 2. Inactivating mutations in near-complete HIV-1 genomes
Clone Defectivegene(s)
In-frame
stop codona
Frameshift
mutationa
Altered
initiation
codona
Plasmid
vectord
GenBank
accession
no.
92UG037.1 pol 3144 pCRII U51190
92BR025.8 pol 2141, 3115 4131 pCRII U52953
94UG114.1 None pTZ18Mlu1 U88824
84ZR085.1 gag/pol 1692 pUC19 U88822
93BR020.1 None pCR2.1 AF005494
90CF056.1 None pCR2.1 AF005496
92RW009.6 gag 213 pTZ18Mlu1 U88823
93BR029.4 gag 260, 472 pTZ18Mlu1 AF005495
92NG083.2 gag, vpu 360 5462b 157 pTZ18Mlu1 U88826
92NG003.1c vpr, vpu, nef 5024b, 5485b 8113 pTZ18Mlu1 U88825
a Numbers indicate the position of the inactivating mutation within the sequence.
b Frameshift mutations associated with more extensive nucleotide sequence deletions (10 to 16 bp).
c 92NG003.1 also has a 33-bp deletion in the V3 loop region of env.
d Genomes were subcloned either by T/A overhang into pCRII or by MluI sites in the primer sequences into pTZ18Mlu1.
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gag and env phylogenetic trees (Fig. 1), suggest that 93BR020.1
and 90CF056.1 represent nonrecombinant members of sub-
types F and H, respectively.
Very similar data were also obtained when 92BR025.8,
92UG037.1, 84ZR085.1, and 94UG114.1 were subjected to
diversity plot analysis with the same set of reference sequences
(Fig. 2, panels 3 to 6). Again, distance curves exhibited very
similar profiles indicating approximate equidistance among the
strains analyzed, except when viruses from the same subtype
were compared. For example, in panel 3, distances between
92BR025.8 (putative subtype C) and U455, 93BR020.1,
90CF056.1, NDK, and C2220 are depicted. As expected, the
C2220 plot falls clearly below all others, indicating the lower
level of sequence divergence between viruses from the same
subtype (ranging from 4% in pol to 12% in env). Importantly,
however, inter- and intradiversity plots follow each other very
closely; i.e., the same genomic regions exhibit proportionally
higher and lower levels of divergence (also see panels 4 to 6).
Thus, at the level of both inter- and intrasubtype comparisons,
there was no evidence of mosaicism in the genomes of these
four viruses. Together with the results in Fig. 1, this suggests
that these strains represent nonmosaic members of subtypes A
(92UG037.1), C (92BR025.8), and D (84ZR085.1 and
94UG114.1), respectively.
By contrast, the diversity plots of the putative recombinants
92RW009.6 and 93BR029.4 exhibited disproportionate levels
of sequence divergence from different subtypes along their
genome, consistent with their discordant branching orders in
gag and env trees. As shown in Fig. 2, panel 7, 92RW009.6 is
most similar to the subtype C strain C2220 in the 59 half of gag,
most of pol, vif, vpr, as well as nef (the dark blue curve falls
below all others). However, in the 39 end of gag, the 59 end of
pol, and most of env, 92RW009.6 is most similar to the subtype
A strain U455 (the red curve falls below all the others). Sim-
ilarly in panel 8, 93BR029.4 is most similar to the subtype B
strain LAI (black curve) in gag, pol, and vpr, while it is most
similar to the putative subtype F strain 93BR020.1 (magenta
curve) in the vif, env, and nef regions. In each case, the mag-
nitude of the difference between the new sequence and the
most similar subtype was no greater than the diversity seen
within subtypes. Thus, these data suggest that 92RW009.6 and
93BR029.1 represent mosaics, comprised of subtypes A/C and
B/F, respectively. In each case, the plots suggested several (at
least four) crossovers; these are the minimum number of re-
FIG. 1. Phylogenetic relationships of the newly characterized viruses (highlighted) to representatives of all major HIV-1 (group M) subtypes in gag and env regions.
Trees were constructed from full-length gag and env nucleotide sequences by using the neighbor-joining method (see the text for details of the method). Horizontal
branch lengths are drawn to scale (the scale bar represents 0.02 nucleotide substitution per site); vertical separation is for clarity only. Values at the nodes indicate the
percent bootstraps in which the cluster to the right was supported (bootstrap values of 75% and higher are shown). Asterisks denote two hybrid genomes with discordant
branching orders in gag and env trees. Brackets on the right represent the major sequence subtypes of HIV-1 group M. Trees were rooted by using SIVcpzGAB as an
outgroup.
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FIG. 2. Diversity plots comparing the sequence relationships of the newly characterized viruses to each other and to reference sequences from the database. In each
panel, the sequence named above the plots is compared to the sequences listed on the right (sequences are color coded). U455, LAI, C2220, and NDK are published
reference sequences for subtypes A, B, C, and D, respectively (45). Distance values were calculated for a window of 500 bp moving in steps of 10 nucleotides. The x
axis indicates the nucleotide positions along the alignment (gaps were stripped and removed from the alignment). The positions of the start codons of the gag, pol, vif,
vpr, env, and nef genes are shown. The y axis denotes the distance between the viruses compared (0.05 5 5% divergence).
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combination breakpoints, since the window size used makes it
unlikely that recombinant regions shorter than 500 bp would
be detected.
Finally, inspection of the diversity plots for 92NG003.1 and
92NG083.2 also revealed disproportionate levels of sequence
variation, although not as pronounced as for 92RW009.6 and
93BR029.4. As shown in Fig. 2, panels 9 and 10, 92NG003.1
and 92NG083.2 are equidistant from members of subtypes A,
C, D, F, and H (as well as B and “E” [data not shown]) for
most of their genome, suggesting that they represent an inde-
pendent subtype, i.e., subtype G. However, in the vif/vpr re-
gion, the U455 distance plot falls below all others (including
the 92NG003.1/92NG083.2 distance plot depicted in green in
panels 9 and 10), suggesting a disproportionately closer rela-
tionship to subtype A. Assuming that U455 is nonmosaic, these
results suggest that both 92NG003.1 and 92NG083.2 contain
short fragments of subtype A sequence in the central region of
their genome.
Exploratory tree analyses. To examine the phylogenetic po-
sition of the newly derived strains relative to each other and to
the reference sequences over the entire genome, we performed
exploratory tree analyses by using the same multiple genome
alignment generated for the diversity plots (Fig. 3). A total of
79 trees were constructed for overlapping fragments of 500 bp,
moving in 100-bp increments along the alignment. As ex-
pected, four genomes that clustered in different subtypes in
different parts of their genome were identified (representative
trees are depicted in Fig. 3A). These included 93BR029.4,
which alternated between subtypes F and B, 92RW009.6,
which alternated between subtypes A and C, and 92NG083.2
and 92NG003.1, which grouped either independently or within
subtype A. Interestingly, the last two strains exhibited distinct
patterns of mosaicism. In trees spanning the region from 3501
to 4000, 92NG003.1 clustered within subtype A while
92NG083.2 clustered independently, presumably representing
subtype G (Fig. 3B). In contrast to these strains, there was no
evidence for a hybrid genome structure in 92UG037.1,
92BR025.8, 94UG114.1, 84ZR085.1, 93BR020.1, or 90CF056.1.
As shown in Fig. 3A, these viruses branched consistently in all
regions analyzed. Based on these findings and the results of the
diversity plots, we thus concluded that 6 of the 10 selected
HIV-1 strains represent nonrecombinant reference strains for
subtypes A (92UG037.1), C (92BR025.8), D (94UG114.1 and
84ZR085.1), F (93BR020.1), and H (90CF056.1), respectively,
while four are intersubtype recombinants.
Recombination breakpoint analysis in 92RW009.6 and
93BR029.4. To map the location of the recombination break-
points in 92RW009.6 and 93BR029.4, we used bootstrap plots
and informative site analyses (18, 52, 53). Unrooted trees
which included U455, 92UG037.1, LAI, MN, OYI, SF2, RF,
C2220, 92BR025.1, NDK, ELI, Z2Z6, 93BR020.1, and
90CF056.1 were constructed; then the magnitudes of the boot-
strap values supporting (i) the clustering of 92RW009.6 with
members of subtype A (U455 and 92UG037.1) or C (2220 and
92BR025.8) and (ii) the clustering of 93BR029.4 with members
of subtype B (LAI, MN, OYI, MN, and RF) or F (92BR020.1)
were determined (in the latter case, subtype D viruses were
excluded because of their known close relationship to subtype
B viruses). Figure 4 depicts the results of 797 such phylogenetic
analyses generated for each genome, performed on a window
of 500 nucleotides and moving in steps of 10 nucleotides. Very
high bootstrap values (.80%) supporting the clustering of
92RW009.6 with subtype C were apparent in gag, the 39 two-
thirds of pol, and nef. By contrast, significant branching of
92RW009.6 with subtype A was apparent in the gag/pol overlap
and the env region. In a small region (positions 4000 to 4200)
in the middle of the genome, 92RW009.6 appeared not to
cluster significantly with either subtype, but further inspection
revealed that this was due to a small number of informative
sites. These data thus indicated four points of recombination
crossovers between subtypes A and C (Fig. 4A). A similar
analysis identified six recombination breakpoints between sub-
types B and F in 93BR029.4 (Fig. 4B). These included two
more (in gag) than were apparent from the diversity-plot anal-
ysis (compare Fig. 2), indicating a greater sensitivity of this
approach.
To map the recombination crossover points in 92RW009.6
and 93BR029.1 more precisely, we examined the distribution
of phylogenetically informative sites supporting alternative
tree topologies (52, 53). Briefly, this was done in a four-se-
quence alignment which included the query sequence, a rep-
resentative of each of the two subtypes presumed to have been
involved in the recombination event, and an outgroup. Break-
points were identified by looking for statistically significant
differences in the ratios of sites supporting one topology over
another. Consistent with the bootscanning data, this analysis
identified four breakpoints in 92RW009.6 (Table 3) and six in
93BR029.4 (Table 4). A schematic representation of the mo-
saic genomes of 92RW009.6 and 93BR029.4 is depicted in Fig.
6 (below).
Recombination breakpoint analysis in 92NG003.1 and
92NG083.2. Because of the lack of a full-length subtype G
reference sequence, recombination breakpoint analysis of
92NG003.1 and 92NG083.2 required a different approach. The
analyses, summarized in Fig. 2 and 3, suggested that these two
viruses contained subtype A sequences in the middle of their
genome. To attempt to confirm this and to define the extent of
these putative subtype A fragments, we performed a more
detailed diversity plot analysis of the viral middle region (be-
tween positions 3000 and 6000) by using different viral strains
and window sizes (ranging from 200 to 400 bp) to examine the
extent of sequence divergence of 92NG083.2 and 92NG003.1
from members of other subtypes, including subtype A. Figures
5A and B depict representative results (with a window size of
300 bp moving in steps of 10 bp along the alignment). Similar
to the data shown in Fig. 2, the two “subtype G” viruses are
roughly equidistantly related to members of subtypes A
(U455), C (C2220), and D (NDK), except for two regions in
92NG003.1 and one region in 92NG083.2, where both viruses
are disproportionately more closely related to U455 than they
are to each other (the red line drops below the green line). By
noting the points at which the “G”-A distance increases or
decreases relative to the others, we could tentatively identify
recombination breakpoints. For example, at position 3400 in
Fig. 5A, the U455 plot (red) falls whereas the C2220 (blue),
NDK (yellow), and 92NG083.2 (green) plots do not, and
around position 3600, the U455 plot crosses the 92NG083.2
plot. Bearing in mind the window size of 300 nucleotides, this
finding suggested that a recombination crossover occurred
around position 3500. Similar “G”-A plot crossings around
positions 3800, 4200, and 5200 in Fig. 5A and around positions
4200 and 4800 in Fig. 5B suggested additional recombination
breakpoints.
We then constructed phylogenetic trees by using the regions
of sequence defined by these putative breakpoints (Fig. 5C).
This analysis generally supported the conclusions drawn from
the diversity plots (i.e., 92NG003.1 clustered with subtype A
viruses in the region between 3501 and 3800, whereas
92NG083.2 did not; and both 92NG003.1 and 92NG083.2 clus-
tered with subtype A viruses in the region 4201 and 4800).
However, neither the diversity plot nor the tree analysis al-
lowed us to define the boundaries of the subtype A fragments
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FIG. 3. Exploratory tree analysis. (A) Neighbor-joining trees were constructed for a 500-bp window moving in increments of 100 bp along the multiple genome
alignment. Trees depicting discordant branching orders among the newly determined sequences are shown (hybrid sequences are boxed and color coded). The position
of each tree in the alignment is indicated; subtypes are identified by curved brackets. Numbers at the nodes indicate the percentage of bootstrap values with which the
adjacent cluster is supported (only values above 80% are shown). Branch lengths are drawn to scale. (B) Summary of the subtype assignments of the four recombinants
illustrated in panel A.
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with certainty. Nevertheless, the data indicated that (i) both
92NG083.2 and 92NG003.1 represent G/A recombinants, (ii)
they are the result of different recombination events because
some of their breakpoints are clearly different, and (iii)
92NG083.2 probably encodes a nonrecombinant pol gene. A
schematic representation of the mosaic genomes of 92NG083.2
and 92NG003.1 is shown in Fig. 6, with shaded areas indicating
regions of uncertain subtype assignment.
Reevaluation of the phylogenetic position of subtype G vi-
ruses in the gp41 region. We (19) and others (40) previously
reported that the env genes of subtype “G” viruses are chi-
meric, with sequences encoding the intracellular portion of
gp41 clustering in subtype A. We were therefore surprised that
neither the diversity plot nor the exploratory tree analysis pro-
vided evidence for a closer relationship of 92NG003.1 and
92NG083.2 to U455 and 92UG037.1 in this region. To inves-
tigate this further, we performed extensive tree analyses in the
vpu/env region, including as many reference sequences for the
various group M subtypes as were available (Fig. 7; for sub-
types B and “E,” only a few representatives are shown). The
results revealed that a number of viruses previously classified
as subtype A in the extracellular domain of env (gp120) fell
into subtype G in the vpu region (boxed viruses in Fig. 7A and
B). Exclusion of these obvious recombinants from gp41 tree
analyses changed the grouping of 92NG003.1 and 92NG083.3
as well as that of all other subtype G viruses. Instead of falling
into a larger “subtype A cluster” (labelled “A?” in Fig. 7C),
they grouped independently from both subtype A and E vi-
ruses, i.e., as subtype G, with high bootstrap values (Fig. 7D;
also note that VI525 clusters in subtype H in the intracellular
region of gp41, and not in subtype G, as assumed in reference
19). The inadvertent inclusion of recombinants was thus re-
sponsible for our previous erroneous classification of subtype
G viruses as “A” at the 39 end of gp41.
Subtype-specific genome features. Having classified the 10
new viruses with respect to their subtype assignments, we ex-
amined their sequences for clade-specific signature sequences.
Comparing deduced amino acid sequences gene by gene, we
found several subtype-specific features (Fig. 8). For example,
most subtype D viruses (including 84ZR085.1 and 94UG114.1)
contain an in-frame stop codon in the second exon of tat, which
removes 13 to 16 amino acids from the carboxy terminus of the
Tat protein (Fig. 8A). Similarly, all subtype C viruses (includ-
ing 92BR025.8) contain a stop codon in the second exon of rev,
which would be predicted to shorten this protein by 16 amino
acids (Fig. 8B). Subtype C viruses also contain a 15-bp inser-
tion at the 59 end of the vpu gene (Fig. 8C), which extends the
putative membrane-spanning domain of the Vpu protein by 5
amino acids (data not shown). Although these changes are
unlikely to alter the function of the respective gene products in
a major way (e.g., the known functional domains of both Tat
FIG. 4. Recombination breakpoint analysis for 92RW009.6 and 93BR029.4.
(A) Bootstrap plots depicting the relationship of 92RW009.6 to representatives
of subtype A (red) and C (blue), respectively. Trees were constructed from the
multiple genome alignment, and the magnitude of the bootstrap value support-
ing the clustering of 92RW009.6 with U455 and 92UG037.1 (subtype A) or with
C2220 and 92BR025.8 (subtype C), respectively, was plotted for a window of 500
bp moving in increments of 10 bp along the alignment. Regions of subtype A or
C origin are identified by very high bootstrap values (.90%). Points of crossover
of the two curves indicate recombination breakpoints. The beginnings of gag, pol,
vif, vpr, env, and nef open reading frames are shown. The y axis indicates the
percentage of bootstrap replicates which support the clustering of 92RW009.6
with representatives of the respective subtypes. (B) Bootstrap plots depicting the
relationship of 93BR029.4 to representatives of subtypes B (black) and F (ma-
genta), respectively. Analyses are as in panel A, except that the bootstrap values
supporting the clustering of 93BR029.4 with SF2, OYI, MN, LAI, and RF
(subtype B) or with 93BR020.1 (subtype F), respectively, were plotted. Subtype
D viruses were excluded from this analysis because of their known close rela-
tionship to subtype B viruses.
TABLE 3. Informative-site analysis of 92RW009.6
Regiona Subtype
No. of informative sites in:
Subtype A
(U455)
Subtype C
(C2220)
Outgroup
(NDK)
1–1037 C 8 32 8
1085–1940 A 17 5 4
1986–5288 C 18 99 27
5293–7238 A 60 9 13
7254–8431 C 12 55 12
a Numbers mark positions in the four-sequence alignment which includes the
untranslated leader sequence (1 to 120), gag (121 to 1537), pol (1370 to 4340), vif
(4285 to 4856), vpr (4799 to 5073), the first tat exon (5054 to 5271), vpu (5276 to
5488), env (5406 to 7726), nef (7727 to 8313), and the 39 LTR (7991 to 8468).
Position 8468 does not correspond to the end of the LTR but is the last position
in the alignment after gaps have been tossed. The 59 LTR is not included in the
alignment.
TABLE 4. Informative-site analysis of 93BR029.4
Regiona Subtype
No. of informative sites in:
Subtype B
(LAI)
Subtype F
(93BR020.1)
Outgroup
(C2220)
1–735 B 18 6 3
755–896 F 1 10 0
930–4247 B 99 10 14
4340–4668 F 2 15 1
4787–5166 B 15 0 5
5244–8242 F 15 139 13
8250–8429 B 13 0 0
a See Table 3, footnote a.
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FIG. 5. Recombination breakpoint analysis of 92NG083.2 and 92NG003.1. (A and B) Diversity plots comparing the sequence relationships of 92NG003.1 and
92NG083.2 to each other and to reference sequences from the database. In both panels, the sequence named above the plots is compared to the sequences listed on
the right (sequences are color coded). U455, C2220, and NDK are published reference sequences for subtypes A, C, and D, respectively (45). Distance values were
calculated for a window of 300 bp moving in steps of 10 nucleotides. The x axis indicates the nucleotide positions along the alignment (gaps were stripped and removed
from the alignment). The positions of the start codons of the vif, vpr, and env genes are shown. The y axis denotes the distance between the viruses compared (0.05 5
5% divergence). (C) Neighbor-joining trees depicting discordant branching orders of 92NG003.1 and 92NG083.2 in regions delineated by breakpoints identified in
panels A and B (hybrid sequences are boxed and color coded). The position of each tree in the alignment is indicated; subtypes are identified by curved brackets.
Numbers at the nodes indicate the percentage of bootstrap values with which the adjacent cluster is supported (only values above 80% are shown). Branch lengths are
drawn to scale.
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and Rev proteins are not affected by these changes), it is
possible that they could influence their mechanism of action in
a subtle (but nevertheless biologically important) manner.
However, direct experimentation is necessary to examine this
possibility.
Inspection of the sequences also revealed the lack of a pre-
viously identified signature sequence in one of the newly char-
acterized viruses. 92BR025.8 was found to encode only two
potential NF-kB binding sites in its core enhancer region (data
not shown). By contrast, all other subtype C viruses, including
several African isolates from Ethiopia, Zambia, and Malawi
(59), as well as two additional isolates from Brazil and two
from India (16), encode three NF-kB binding sites.
Construction of a replication-competent 94UG114.1 provi-
rus. Long-PCR approaches generally fail to generate replica-
tion-competent clones of HIV-1 because of sequence redun-
dancies in the LTRs. Portions of the LTRs have to be added in
additional cloning steps to generate a complete set of regula-
tory sequences required for viral DNA synthesis and reverse
transcription. Although LTR sequences from any subtype (e.g.,
subtype B) would probably restore functionality, such chimeric
proviruses could differ in their biological properties (56). To
generate genomes that represent more faithfully their corre-
sponding isolates, we have devised an amplification and clon-
ing strategy that allows the construction of a replication-com-
petent provirus in a two-step process (Fig. 9A). Briefly, both
the 59 LTR and a fragment containing the remainder of the
genome are amplified from the same isolate DNA by regular
PCR and long-PCR approaches, respectively. Both products
are then subcloned into a plasmid which contains restriction
enzyme sites suitable for the subsequent joining of the two
fragments into a single vector. For 94UG114.1, we used NarI,
a unique enzyme site present in the primer binding site of all
known group M and O strains of HIV-1 (45), in combination
with MluI, a non-cutter of almost all HIV-1 genomes (53 of 55
complete HIV-1 sequences in the database are not cleaved by
MluI [45]). The latter enzyme site was introduced via the PCR
primers (Fig. 9A).
Following reconstruction, the 94UG114.1 full-length clone
was transfected into 293T cells, together with positive (SG3
[20]) and negative (plasmid) control constructs. Analysis of
culture supernatants revealed positive RT and p24 activity,
consistent with the expression of functional gag, tat, rev, and pol
gene products. Subsequent cell-free transmission of culture
fluids to PHA-stimulated normal donor PBMCs established
that 94UG114.1 was infectious for and grew well in natural
target cells (Fig. 9B). Moreover, its replication profile was
comparable to that of the highly cytopathic SG3 strain (20),
indicating efficient env-mediated fusion and spread in the cul-
ture. These results thus document that the long-PCR-derived
94UG114.1 genome encodes functional gene products and rep-
resents a replication competent proviral clone (reconstruction
of some of the other clones is under way).
DISCUSSION
Non-subtype B viruses cause the vast majority of new HIV-1
infections worldwide, yet they are only infrequently studied
with respect to their biological, immunogenic, and pathogenic
properties, in part because well-characterized virological ref-
erence reagents are still lacking. In this study, we selected 10
non-subtype B isolates from various geographic locations and
cloned their genomes by using long-PCR or lambda phage
techniques. All the genomic clones were derived from primary
(PBMC-derived) isolates and thus represent biologically rele-
vant viruses. Detailed phylogenetic analysis identified six of
these viruses as nonrecombinant members of subtypes A, C, D
(two), F, and H, which more than doubles the number of
non-subtype B reference strains available (Table 5). Among
these, the near-full-length genomes of 93BR020.1 and
90CF056.1 represent the first such strains for subtypes F and
H, respectively. The four other viruses were found to represent
complex mosaics of subtypes A and C, A and G (two), and B
and F. Both A/G recombinants originated from Nigeria but
must have arisen from independent recombination events since
they are not closely related and differ in their patterns of
mosaicism. One of these (92NG083.2) appears to contain only
a single short (perhaps 600-bp) segment of subtype A origin in
the vif/vpr region, and in the absence of (as yet) any full-length
subtype G virus, it thus serves as a (nonmosaic) subtype G
representative for the gag, pol, env, and nef regions. Impor-
tantly, 9 of the 10 genomes were generated in such a way that
they can be tested for biological activity following a simple
reconstruction step. An example of such a reconstructed ge-
nome giving rise to replication competent virus (94UG114.1)
demonstrates that this approach is feasible.
HIV-1 group M subtypes. The presence of subtypes within
the M group of HIV-1 was first suggested in 1992 on the basis
of phylogenetic analysis of env gene sequences, which revealed
five approximately equidistant clades within the HIV-1 tree
(44). With the determination of additional HIV-1 sequences of
diverse origins, 10 subtypes (A to J) have now been described
(29, 30, 35, 45), although full-length env sequences are not yet
available for subtypes I and J (29, 30). Phylogenetic analysis of
gag gene sequences yielded very similar overall results (34),
although for some viruses a comparison of their phylogenetic
positions in the different trees revealed that they were recom-
binants (52, 53). Sequences for the third major retrovirus gene,
pol, have thus far been available only for representatives of
four subtypes (45). The data presented in this study thus allow
the first estimate of a phylogeny for full-length pol gene se-
quences based on the sequence information of seven subtypes.
The results shown in Fig. 10 are remarkably consistent with
those of trees from gag and env regions (compare Fig. 1),
FIG. 6. Inferred structures of the four recombinant genomes characterized in
this study. Regions of different subtype origin are color coded. Uncertain break-
points are hatched. LTR sequences were not analyzed and are shown as open
boxes.
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FIG. 7. Phylogenetic relationships of subtype G (and “E”) viruses in vpu and env regions. Trees were constructed for the vpu (A), 59 env (B), and 39 env (C and
D) regions to reexamine the subtype associations of previously classified subtype A, G, and “E” viruses (19). Several strains (boxed) previously thought to represent
subtype A (panel B) were found to cluster in subtype G viruses in the vpu region (panel A). Exclusion of these G/A recombinants changed the topology of trees derived
from the intracellular gp41 domain (panels C and D). VI525 (highlighted by an asterisk) was identified as a G/H recombinant, clustering in subtype G and H in the
extracellular and intracellular portions of env, respectively. All known representatives for the different subtypes were included in the analysis, and only a few
representatives for subtypes B and “E” are shown.
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FIG. 8. Subtype-specific genome features. (A) Alignment of deduced Tat (region encoded by second exon) amino acid sequences. Consensus sequences were
generated for available representatives of all major subtypes (question marks indicate sites at which fewer than 50% of the viruses contain the same amino acid residue).
Dashes denote sequence identity with the consensus sequence, while dots represent gaps introduced to optimize the alignments. A vertical box highlights a premature
Tat protein truncation (asterisk) which is present in 11 of 15 subtype D and 4 of 52 subtype B viruses (frequencies are listed in the column on the right). (B) Alignment
of deduced Rev (region encoded by the second exon) protein sequences. (C) Alignment of deduced Vpu protein sequences.
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demonstrating that the phylogenetic structure implied by the
current subtype classification scheme is a real phenomenon.
HIV-1 intersubtype recombinants. While the majority of
HIV-1 group M sequences fall neatly into the various subtypes
discussed above, a substantial minority do not. That is, the
phylogenetic position of many viruses differs depending on the
genomic region analyzed, indicating that they are mosaics gen-
erated by recombination. In our study, 4 of 10 geographically
diverse isolates were found to represent intersubtype recom-
binants. Similarly, 7 of 12 full-length non-subtype B sequences
in the database represent recombinants (Table 5). These num-
bers do not necessarily indicate the actual prevalence of mosaic
viruses, because the viruses were not systematically sampled;
for example, three of the recombinants in the database are
“subtype E” viruses, all descended from a common ancestral
recombinant virus and selected for study because of specific
interest in their role in the Thai AIDS epidemic (7, 18). How-
ever, numerous subgenomic sequences have been identified as
mosaic (4, 8, 31, 52, 54, 66, 71). In our initial study (52), about
10% of the database sequences appeared to be intersubtype
recombinants, and more recent surveys suggest that this pro-
portion may be increasing (8, 66, 71).
Given the apparent prevalence of mosaic viruses, it is clear
that subtype-specific reference strains can be defined as such
only after comprehensive recombination analysis. Small sub-
genomic fragments or even full-length gag and env sequences
FIG. 9. Generation of replication-competent proviral clones from long-PCR products. (A) Construction of a replication-competent 94UG114.1 provirus from two
separately amplified genomic regions (see the text for details). (B) Replication potential of 94UG114.1 in primary PBMC cultures. Normal donor PBMCs were isolated,
PHA stimulated and then infected with equal amounts (based on p24 antigen content) of 94UG114.1 and SG3 viruses derived from 293T transfections of proviral DNA.
Virus production was monitored by measuring supernatant RT activity at 3-day intervals as described previously (20). Supernatants from a mock-transfected culture
served as a negative control.
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TABLE 5. Full-length group M HIV-1 sequences in the database
Subtype Clonea Source Cloningmethod
Replication
competence Defective gene(s)
GenBank
accession no.
A U455 U937 Phage 2 vpr, vpu, env M62320
92UG037.1 PBMC PCR 2 pol U51190
B LAI/BRU PBMC Phage 1c None K02013
BH10 H9 Phage 1c vpr, nef X01762
PV22 H9 Phage NA vpr K02083
PM213 NAe NA NA vpr, vpud D86069
MCK1 NA NA NA vpr D86068
LW12-3 H9 Phage 1c vif, vpr U12055
HXB2 H9 Phage 1 nef, vpr, vpud M38432
TH475b TH4-7-5 PCR 2 vpr L31963
NY5 A3.01 Phage 2 vpud M38431
SF2 HUT-78 Phage 1 vpu K02007
P89.6 PBMC Phage 1c None U39362
RF H9 Phage 2 gag, vpu M17451
ACH320.2A.1.2 PBMC Phage 1 None U34603
ACH320.2A.2.1 PBMC Phage 1 None U34604
AD8 PBMC Phage 1c vpud AF004394
D31 NA NA NA None U43096
CAM1 NA NA NA vpu D10112
F12 HUT-78 NA NA vpr Z11530
SG3 HUT-78 Phage 1 vpu L02317
WEAU H9 Phage 1 nef U21135
YU2 Brain tissue Phage 1c vpud M93258
YU10 Brain tissue Phage 2 pol M93259
MN H9 Phage 2 pol, nef, vpu M17449
HAN2/3 MT2 Phage 2 env U43141
JRCSF PBMC Phage 1c None M38429
JRFLb PBMC Phage 1c None U63632
OYIb PBMC Phage 2 vpud M26727
C18MBCb PBMC PCR 2 nef U37270
MANCb Kidney tissue PCR 2 None U23487
WR27 PBMC PCR 2 NA U26546
C C2220 PBMC PCR 2 tat U46016
92BR025.8 PBMC PCR 2 pol U52953
D NDK CEM Phage 1 None M27323
Z2Z6 A3.01 Phage 1c None M22639
ELI PBMC Phage 1c None X04414
84ZR085.1 PBMC Phage 2 gag, pol U88822
94UG114.1 PBMC PCR 1c None U88824
F 93BR020.1 PBMC PCR 2 None AF005494
H 90CF056.1 PBMC PCR 2 None AF005496
R 90CF402.1 A/E PBMC Phage 1c vif, vpud U51188
93TH253.3 A/E H9 Phage 2 env, vpud U51189
CM240 A/E PBMC PCR 2 vpud U54771
MAL A/D/I/? PBMC Phage 1c vpud K03456
ZAM184 A/C PBMC PCR 2 None U86780
92RW009.6 A/C PBMC PCR 2 gag U88823
92NG003.1 A/G PBMC PCR 2 vpr, vpu, env, nef U88825
92NG083.2 A/C PBMC PCR 2 gag, vpu U88826
93BR029.4 B/F PBMC PCR 2 gag AF005495
IBNGb A/G PBMC PCR 2 tat L39106
Z321Bb A/G/I/? CEM3/HUT-78 PCR 2 vpr, vpu U76035
a Boldface clones are those generated in this study. Brackets indicate variants from the same isolate. NL4-3 is not included because it is an artificial recombinant
between NY5 and LAI.
b Genome derived from multiple PCR fragments.
c Infectious molecular clone after reconstruction.
d Defective vpu gene due to loss of start codon.
e NA, not available.
F
F
F
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are not sufficient to identify all hybrid genomes. Although
multiple crossovers are a characteristic feature of retroviral
recombination and have been found in many of the mosaic
HIV-1 genomes examined (7, 19, 53, 60, 62), the examples of
92NG003.1 and 92NG083.2 demonstrate that crossovers may
be confined to regions outside of gag and env. Thus, elimina-
tion of the possibility that a virus is recombinant requires the
determination of substantial (if not all) portions of its genome.
As a consequence, subtype-specific reference reagents, such as
immunogens for cross-clade CTL and neutralization assays,
should be derived only from viral isolates for which a complete
genome has been characterized.
These considerations emphasize the need for detailed anal-
yses involving reliable methods for identification of recombi-
nant viral sequences. We have found that diversity plots, de-
picting the distance between a query sequence and a set of
reference sequences in moving windows along the genome,
represent an excellent initial screening tool. The extent of
sequence divergence (between any pair of viruses) varies along
the genome, but since all plots are shown in the same graph,
particular regions where the query sequence is anomalously
highly similar to (or divergent from) other sequences can be
readily identified. For example, this approach uncovered the
subtype A-like regions in the middle of the putative “subtype
G” genomes 92NG003.1 and 92NG083.2 (Fig. 2, panels 9 and
10; Fig. 5A and B). (An alternative program available from the
database [termed RIP] [63] uses a similar approach. RIP iden-
tifies windows of sequence in which the query sequence is
significantly more similar to the consensus sequence of one
particular subtype; if the most similar subtype varies along the
sequence, this is a sign that the query sequence is probably a
recombinant.) However, the results of such analyses relying
only on extents of sequence divergence must be treated with
some caution, because they are susceptible to variation in evo-
lutionary rate in different lineages. Once suspicious regions
have been identified, phylogenetic analyses of windows of se-
quence around these regions can be used to look for discordant
branching orders and to identify the subtypes likely to have
been involved in the recombination event. The bootstrap value
supporting the clustering of the query sequence with sequences
of the supposed “parental” subtypes can be examined, again in
moving windows along the genome. (The bootscanning ap-
proach of Salminen et al. [57] is very similar to this.) Finally,
informative site analysis can be used to map as precisely as
possible the breakpoints of the putative recombination events
(52, 53).
Clearly, recombination analysis relies on the availability of
accurately defined nonmosaic reference sequences. Thus, lo-
cation of the breakpoints in the two G/A recombinant viruses
identified here must remain tentative because of the lack of
such reference sequences for subtype G. The precise positions
of breakpoints in the recently characterized Thai and Central
African Republic “subtype E” viruses are similarly uncertain
(7, 18), in this case because of the lack of a complete nonmo-
saic subtype E reference sequence. It should also be empha-
sized that currently designated reference sequences may re-
quire revision in the future. For example, the inadvertent
inclusion of recombinant “reference” sequences in previous
tree analyses (19, 40) led to an incorrect subtype assignment of
subtype G gp41 sequences (Fig. 7). It is therefore possible that
as more sequences become available, one or more of the viral
sequences currently classified as nonrecombinant may be iden-
tified as a hybrid.
Relevance of the HIV-1 subtype nomenclature. The various
subtypes differ in their geographic dissemination, and so the
subtype designations have been powerful molecular epidemi-
ological markers for tracking the course of the global pandemic
(5, 24, 72). For example, the AIDS epidemic in Thailand was
initially believed to have resulted from a single introduction of
HIV-1. However, genetic analysis revealed that there were in
fact two distinct epidemics of different origins: intravenous
drug users were infected with subtype B viruses prevalent in
the United States and Europe, while commercial sex workers
and their contacts harbored (recombinant) “subtype E” viruses
common only in Africa (7, 18, 25, 39, 43, 47). These, and other
examples (5), have demonstrated the utility of subtyping as a
tool to monitor the geographic distribution, prevalence, and
intermixing of HIV-1 variants. Nevertheless, some aspects of
the current subtype nomenclature are clearly arbitrary and are
based on historical facts rather than the application of consis-
tent nomenclature rules. For example, subtype B viruses con-
sistently cluster with subtype D viruses in phylogenetic trees of
different genes (61) (Fig. 1 and 10), and the divergence be-
tween these two subtypes is hardly any greater than the diver-
sity seen within some other subtypes (e.g., subtype A). This
suggests that the HIV-1 epidemic in North America was initi-
ated by a virus that could have been classified as subtype D.
Instead, subtype B viruses were designated as a separate sub-
type, because they happened to be the sole initial focus of
attention. Moreover, subtypes are not the only appropriate
level of classification in epidemiological tracking. Other
(chance?) epidemiological events have led to identifiable geo-
graphic and phylogenetic subclusters within subtypes, such as
the Thai B clade (frequently referred to as B9) or subclusters
with subtype A. Nevertheless, the current subtype classification
FIG. 10. Phylogeny of full-length pol sequences of seven major HIV-1 group
M subtypes. The sequences determined in this study are highlighted. Horizontal
branch lengths are drawn to scale (the scale bar represents 0.02 nucleotide
substitution per site). Vertical separation is for clarity only. Values at the nodes
indicate the percentage of bootstraps in which the cluster to the right was
supported (bootstrap values of 80% and higher only are shown). Brackets on the
right represent the major sequence subtypes of HIV-1 group M. Trees were
rooted by using SIVcpzGAB as an outgroup.
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is likely to remain useful in the molecular epidemiological
context.
The subtype classification would be of even greater interest
if members of the different subtypes were found to differ in
their biological properties. The average values for protein se-
quence diversity among subtypes for Gag, Pol, and Env are 15,
10, and 24%, respectively (subtype B versus D comparisons
were excluded from these calculations for the reasons given
above). The neutral theory of molecular evolution (27) not-
withstanding, it would be surprising if proteins whose se-
quences differ by such an extent did not exhibit at least some
variation in their biological properties. However, no subtype-
specific differences in virus biology have yet been identified.
Extensive studies have shown that subtypes do not correlate
with neutralization serotypes (38, 42, 46, 68), and even T-cell
immune responses appear to be largely independent of genetic
subtypes (3, 6, 15). Members of the various subtypes have also
not been found to differ in second-receptor usage (73, 74), and
a proposed preferential tropism of “subtype E” viruses for
skin-derived Langerhans cells (64) has not been confirmed in
subsequent investigations (9, 50, 51). Thus, current data have
failed to identify simple correlations between phylogenetic lin-
eages and biological phenotypes.
Further consideration of the phylogenetic relationships
within the HIV-1 M group (Fig. 1 and 10) yields some insight
into the apparent lack of phenotypic correlates at the subtype
level. Any subtype-specific property, i.e., a phenotype common
among all members of one subtype but not found among mem-
bers of other subtypes, would have to be due to sequence
changes occurring on the “presubtype” branch for that subtype
(here we define a presubtype branch as that connecting the
common ancestor of a subtype to the common ancestor of the
entire M group). These presubtype branches comprise only a
fraction of the total divergence between contemporary viruses
representing different subtypes. The chances of finding sub-
type-specific biological properties are thus similarly small, be-
cause the genetic changes responsible for these differences
would have to occur on these presubtype branches. In fact,
biologically meaningful sequence changes can occur at any
point in the tree and certainly would not be expected to occur
only (or preferentially) on presubtype branches. An expecta-
tion of biological differences along strict (and all) subtype lines
is thus overly simplistic.
Nevertheless, it would be premature to conclude that there
are no subtype-specific differences in virus biology. A relatively
small number of viral phenotypes have been examined, and
available in vitro assays may be too insensitive to identify subtle
(yet important) differences in viral growth and cell tropism.
Moreover, there are some sequence changes that appear to
have arisen on the presubtype branches, and certain of these
subtype-specific variations occur within genomic regions of
known regulatory function. For example, subtype C viruses
(which comprise about 36% of all globally circulating HIV-1
group M viruses based on the latest WHO estimates) are
characterized by a premature truncation of their rev open read-
ing frame (Fig. 8), an enlarged Vpu protein (Fig. 8), and three
(instead of the common two) copies of a consensus NF-kB
domain (59). Similarly, “subtype E” viruses (which are spread-
ing with increasing rapidity in Asia) differ from other subtypes
in having only one consensus NF-kB site (18). Such changes in
enhancer copy numbers and regulatory proteins may manifest
themselves only after multiple rounds of replication in vivo.
Thus, subtype-specific biological differences may become ap-
parent only in broad-based natural history studies.
Utility of subtype-specific reference reagents. The availabil-
ity of near-full-length representatives for five non-B HIV-1
group M clades, including a reconstructed replication-compe-
tent molecular clone of a subtype D isolate, should greatly
facilitate efforts aimed at determining the biological conse-
quences of HIV-1 genetic diversity and its impact on cellular
and humoral immune responses in the infected host. Clones
and sequences will be useful for identifying cross-clade CTL
epitopes and for generating subtype-specific CTL targets. The
clones will also be useful for the preparation of DNA- or
protein-based subunit vaccines, including cocktails of geneti-
cally diverse immunogens. In this context, it should be noted
that the representatives of subtypes F and H both contain
uninterrupted reading frames. Finally, the full-length se-
quences are critically needed for phylogenetic studies, partic-
ularly of genomic regions other than gag and env. In collabo-
ration with the Los Alamos database, we have compiled a list
of nonmosaic reference sequences for all major HIV-1 genes
(32), which is available at the Los Alamos web site (http://hiv
-web.lanl.gov/subtype/subtypes.html). A similar compilation of
documented intersubtype recombinants is in preparation.
These listings should help investigators interested in subtyping
new sequences to avoid the inclusion of mosaic sequences into
phylogenetic trees.
All clones have been submitted to the National Institutes of
Health Research and Reagent Program, Bethesda, Md., and
all sequences have been recorded in GenBank and are avail-
able on-line through the Los Alamos HIV database. These
reagents are thus available to investigators and manufacturers
interested in the development and testing of HIV vaccines.
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